What is the recommended dose of Levipil (Levetiracetam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Levipil (Levetiracetam)

For chronic epilepsy management, start levetiracetam at 1000 mg/day (500 mg twice daily) in adults, titrating by 1000 mg/day every 2 weeks to a target of 3000 mg/day; for status epilepticus, use 30 mg/kg IV at 5 mg/kg/minute as second-line therapy after benzodiazepines. 1, 2, 3

Chronic Epilepsy Management (Adjunctive Therapy)

Adults (≥16 years)

  • Starting dose: 1000 mg/day divided as 500 mg twice daily 1
  • Titration: Increase by 1000 mg/day every 2 weeks 1
  • Target maintenance dose: 3000 mg/day (1500 mg twice daily) 1
  • Maximum studied dose: 3000 mg/day; higher doses have been used in open-label studies but show no additional benefit 1

Pediatric Patients (4-16 years, Partial Onset Seizures)

  • Starting dose: 20 mg/kg/day in 2 divided doses (10 mg/kg twice daily) 1
  • Titration: Increase by 20 mg/kg every 2 weeks 1
  • Target dose: 60 mg/kg/day (30 mg/kg twice daily) 1
  • Note: If 60 mg/kg/day is not tolerated, the dose may be reduced; mean effective dose in trials was 52 mg/kg/day 1
  • Children ≤20 kg should use oral solution; those >20 kg can use tablets or solution 1

Specific Seizure Types

Myoclonic Seizures (≥12 years with Juvenile Myoclonic Epilepsy):

  • Start at 1000 mg/day (500 mg twice daily), increase by 1000 mg/day every 2 weeks to 3000 mg/day 1
  • Doses lower than 3000 mg/day have not been adequately studied for this indication 1

Primary Generalized Tonic-Clonic Seizures:

  • Adults: Same as above (target 3000 mg/day) 1
  • Children 6-16 years: 60 mg/kg/day as target dose 1

Status Epilepticus (Second-Line Therapy)

Loading Dose for Status Epilepticus

  • Recommended dose: 30 mg/kg IV at 5 mg/kg/minute 2, 3
  • Alternative studied regimen: 1500-2500 mg IV over 5-15 minutes 3
  • Efficacy: 73% seizure cessation rate when used after benzodiazepine failure, comparable to valproate 3

Critical dosing consideration: Lower doses of 20 mg/kg show significantly reduced efficacy (38-67% response rate) and are not recommended 3

Rapid Loading in Emergency Department

  • For known seizure patients requiring ED loading: 1500 mg oral or rapid IV 3
  • Rapid IV loading up to 60 mg/kg has been well tolerated in pediatric studies 4

Important Clinical Considerations

Dosing Pitfalls

  • Avoid underdosing in status epilepticus: The 30 mg/kg dose is critical for efficacy; 20 mg/kg shows only 38% response within 30 minutes 3
  • Children require higher weight-adjusted doses: Apparent body clearance is 30-40% higher in children than adults, necessitating the full 60 mg/kg/day target 5
  • No dose adjustment needed for drug interactions: Levetiracetam does not interact with other antiepileptic drugs, digoxin, warfarin, or oral contraceptives 6

Safety Profile

  • Adverse effects are minimal: Most common include somnolence, fatigue, dizziness, and rarely nausea or transient transaminitis 4, 3
  • Wide safety margin: Accidental overdoses up to 200 mg/kg/day for 55 days have occurred without apparent adverse effects 7
  • No therapeutic drug monitoring required: Unlike phenytoin or valproate 4
  • Monitor complete blood count during maintenance therapy 4

Administration

  • Can be given with or without food 1
  • For oral solution in children, use a calibrated measuring device, not household spoons 1
  • IV formulation has tolerability profile consistent with oral formulation 4

References

Guideline

Treatment of Periodic Lateralized Epileptiform Discharges (PLEDs)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Levetiracetam for Status Epilepticus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.